| | | | |

In Search of a Better Mesothelioma Blood Test

24145636_testtubes

A team from the Center of Molecular Medicine in Bochum, Germany tested the blood of 43 male mesothelioma patients along with 52 control subjects that had been exposed to asbestos but hadn’t developed mesothelioma. Blood was analyzed for the presence of mesothelin, a protein that is the most common blood-based mesothelioma biomarker, and miR-103a-3p, a microRNA gene.

When the team attempted to identify the mesothelioma patients by mesothelin levels alone, they were able to correctly identify 74% of the sick patients. At the same time, the mesothelin-only blood test correctly ruled out mesothelioma in 85% of the healthy control subjects.

The micro RNA gene proved to be a more accurate identifier of mesothelioma. Using the microRNA gene as their only biomarker, the team correctly identified the mesothelioma cases 89% of the time. Unfortunately, the microRNA biomarker was only 63% accurate when it came to ruling out mesothelioma in the control group.

The good news is that, when the two biomarkers were used together, both the sensitivity (ability to correctly identify mesothelioma) and specificity (the ability to correctly rule out mesothelioma in healthy people) were much better. A test using both mesothelin and miR-103a-3p correctly picked up mesothelioma in 95% of the patients who had it. Only 9% of the healthy patients were incorrectly identified as having mesothelioma.

Writing in the online open-access journal PLoS One, author Daniel Weber says, “The obtained results indicate that the use of biomarkers of different molecular classes might be a reasonable approach to assemble a biomarker panel [for mesothelioma].”

Currently, the diagnostic process for malignant mesothelioma is often lengthy and difficult, involving not only blood tests, but imaging studies, tests of lung fluid, and, in most cases, biopsy. Mesothelioma researchers around the globe continue to search for an accurate, non-invasive test that will help doctors identify mesothelioma easier and earlier.

Source:

Weber, DG et al, “Combination of miR-103a-3p and Mesothelin Improves the Biomarker Performance of Malignant Mesothelioma Diagnosis”, Dec. 3, 2014, PLoS One, e114483

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…